Insmed’s Paul Streck Joins Alder Bio as Chief Medical Officer

Xconomy Seattle — 

Alder BioPharmaceuticals (NASDAQ: ALDR) has appointed Paul Streck to serve as chief medical officer, a post he held at his former company, Insmed (NASDAQ: INSM). His experience also includes roles at GlaxoSmithKline (NYSE: GSK), Shire, and Amgen (NASDAQ: AMGN). Alder’s lead drug, eptinezumab, was developed to prevent migraine pain. The Bothell, WA-based company has said it expects to file for FDA approval in the first quarter of this year.